Surrogate Tissue Analysis (eBook, PDF)
Genomic, Proteomic, and Metabolomic Approaches
Redaktion: Burczynski, Michael E.; Rockett, John C.
142,95 €
142,95 €
inkl. MwSt.
Sofort per Download lieferbar
71 °P sammeln
142,95 €
Als Download kaufen
142,95 €
inkl. MwSt.
Sofort per Download lieferbar
71 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
142,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
71 °P sammeln
Surrogate Tissue Analysis (eBook, PDF)
Genomic, Proteomic, and Metabolomic Approaches
Redaktion: Burczynski, Michael E.; Rockett, John C.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Despite rapidly expanding interest in potential applications of surrogate tissue analysis and intense competition to identify and validate biomarkers in appropriate surrogate tissues, very few peer reviewed publications describing the use of this approach have appeared in the scientific press. One of the first publications on this topic, Surrogate
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 4.34MB
Andere Kunden interessierten sich auch für
- Microarray Innovations (eBook, PDF)50,95 €
- Biofunctional Surface Engineering (eBook, PDF)97,95 €
- Roger L. LundbladDevelopment and Application of Biomarkers (eBook, PDF)58,95 €
- OMICS (eBook, PDF)78,95 €
- Synthetic Nucleic Acids as Inhibitors of Gene Expression (eBook, PDF)151,95 €
- Expression Profiling of Human Tumors (eBook, PDF)81,95 €
- Terpenoids Against Human Diseases (eBook, PDF)134,95 €
-
-
-
Despite rapidly expanding interest in potential applications of surrogate tissue analysis and intense competition to identify and validate biomarkers in appropriate surrogate tissues, very few peer reviewed publications describing the use of this approach have appeared in the scientific press. One of the first publications on this topic, Surrogate
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 332
- Erscheinungstermin: 10. November 2005
- Englisch
- ISBN-13: 9781420038095
- Artikelnr.: 52958025
- Verlag: Taylor & Francis
- Seitenzahl: 332
- Erscheinungstermin: 10. November 2005
- Englisch
- ISBN-13: 9781420038095
- Artikelnr.: 52958025
Michael E. Burczynski, John C. Rockett
INTRODUCTION TO SURROGATE TISSUE ANALYSIS. Introduction to Surrogate Tissue
Analysis. GENOMIC APPROACHES. Impact of Sample Handling and Preparation on
Gene Signatures as Exemplified for Transcriptome Analysis of Peripheral
Blood. Blood Genomic Fingerprints of Brain Diseases. Transcriptional
Profiling of Peripheral Blood in Oncology. Blood-Derived Transcriptomic
Profiles as a Means to Monitor Levels of Toxicant Exposure and the Effects
of Toxicants on Inaccessible Target Tissues. Spermatozoal RNAs as Surrogate
Markers of Paternal Exposure. PROTEOMIC APPROACHES. Proteomic Analysis of
Surrogate Tissues: Mass Spectrometry-Based Profiling of the Circulatory
Proteome for Cancer Detection and Stratification. Lymphocyte Integrins:
Potential Surrogate Biomarkers for Evaluation of Endometrial Receptivity.
Nipple Aspirate Fluid to Diagnose Breast Cancer and Monitor Response to
Treatment. METABOLOMICS AND OTHER APPROACHES. Metabonomics: Metabolic
Profiling and Pattern Recognition Analysis of Body Fluids and Tissues for
Characterization of Drug Toxicity and Disease Diagnosis. Comprehensive
Metabolomic Profiling of Serum and Cerebrospinal Fluid: Understanding
Disease, Human Variability, and Toxicity. Lipidomic Analysis of Plasma and
Tissues: Lipid-Derived Mediators of Inflammation and Markers of Disease.
Molecular Detection and Characterization of Circulating Tumor Cells and
Micrometastases in Solid Tumors. Methylation Profiling of Tumor Cells and
Tumor DNA in Blood, Urine, and Body Fluids for Cancer Detection and
Monitoring. FUTURE CONSIDERATIONS FOR SURROGATE TISSUE PROFILING.
Regulatory and Technical Challenges in Incorporating Surrogate Tissue
Profiling Strategies into Clinical Development Programs. Considerations in
the Economic Assessment of the Value of Molecular Profiling. The Impact and
Challenges of Pan-Omic Approaches in Pharmaceutical Discovery and
Development. Current and Future Aspects of Surrogate Tissue Analysis.
References.
Analysis. GENOMIC APPROACHES. Impact of Sample Handling and Preparation on
Gene Signatures as Exemplified for Transcriptome Analysis of Peripheral
Blood. Blood Genomic Fingerprints of Brain Diseases. Transcriptional
Profiling of Peripheral Blood in Oncology. Blood-Derived Transcriptomic
Profiles as a Means to Monitor Levels of Toxicant Exposure and the Effects
of Toxicants on Inaccessible Target Tissues. Spermatozoal RNAs as Surrogate
Markers of Paternal Exposure. PROTEOMIC APPROACHES. Proteomic Analysis of
Surrogate Tissues: Mass Spectrometry-Based Profiling of the Circulatory
Proteome for Cancer Detection and Stratification. Lymphocyte Integrins:
Potential Surrogate Biomarkers for Evaluation of Endometrial Receptivity.
Nipple Aspirate Fluid to Diagnose Breast Cancer and Monitor Response to
Treatment. METABOLOMICS AND OTHER APPROACHES. Metabonomics: Metabolic
Profiling and Pattern Recognition Analysis of Body Fluids and Tissues for
Characterization of Drug Toxicity and Disease Diagnosis. Comprehensive
Metabolomic Profiling of Serum and Cerebrospinal Fluid: Understanding
Disease, Human Variability, and Toxicity. Lipidomic Analysis of Plasma and
Tissues: Lipid-Derived Mediators of Inflammation and Markers of Disease.
Molecular Detection and Characterization of Circulating Tumor Cells and
Micrometastases in Solid Tumors. Methylation Profiling of Tumor Cells and
Tumor DNA in Blood, Urine, and Body Fluids for Cancer Detection and
Monitoring. FUTURE CONSIDERATIONS FOR SURROGATE TISSUE PROFILING.
Regulatory and Technical Challenges in Incorporating Surrogate Tissue
Profiling Strategies into Clinical Development Programs. Considerations in
the Economic Assessment of the Value of Molecular Profiling. The Impact and
Challenges of Pan-Omic Approaches in Pharmaceutical Discovery and
Development. Current and Future Aspects of Surrogate Tissue Analysis.
References.
INTRODUCTION TO SURROGATE TISSUE ANALYSIS. Introduction to Surrogate Tissue
Analysis. GENOMIC APPROACHES. Impact of Sample Handling and Preparation on
Gene Signatures as Exemplified for Transcriptome Analysis of Peripheral
Blood. Blood Genomic Fingerprints of Brain Diseases. Transcriptional
Profiling of Peripheral Blood in Oncology. Blood-Derived Transcriptomic
Profiles as a Means to Monitor Levels of Toxicant Exposure and the Effects
of Toxicants on Inaccessible Target Tissues. Spermatozoal RNAs as Surrogate
Markers of Paternal Exposure. PROTEOMIC APPROACHES. Proteomic Analysis of
Surrogate Tissues: Mass Spectrometry-Based Profiling of the Circulatory
Proteome for Cancer Detection and Stratification. Lymphocyte Integrins:
Potential Surrogate Biomarkers for Evaluation of Endometrial Receptivity.
Nipple Aspirate Fluid to Diagnose Breast Cancer and Monitor Response to
Treatment. METABOLOMICS AND OTHER APPROACHES. Metabonomics: Metabolic
Profiling and Pattern Recognition Analysis of Body Fluids and Tissues for
Characterization of Drug Toxicity and Disease Diagnosis. Comprehensive
Metabolomic Profiling of Serum and Cerebrospinal Fluid: Understanding
Disease, Human Variability, and Toxicity. Lipidomic Analysis of Plasma and
Tissues: Lipid-Derived Mediators of Inflammation and Markers of Disease.
Molecular Detection and Characterization of Circulating Tumor Cells and
Micrometastases in Solid Tumors. Methylation Profiling of Tumor Cells and
Tumor DNA in Blood, Urine, and Body Fluids for Cancer Detection and
Monitoring. FUTURE CONSIDERATIONS FOR SURROGATE TISSUE PROFILING.
Regulatory and Technical Challenges in Incorporating Surrogate Tissue
Profiling Strategies into Clinical Development Programs. Considerations in
the Economic Assessment of the Value of Molecular Profiling. The Impact and
Challenges of Pan-Omic Approaches in Pharmaceutical Discovery and
Development. Current and Future Aspects of Surrogate Tissue Analysis.
References.
Analysis. GENOMIC APPROACHES. Impact of Sample Handling and Preparation on
Gene Signatures as Exemplified for Transcriptome Analysis of Peripheral
Blood. Blood Genomic Fingerprints of Brain Diseases. Transcriptional
Profiling of Peripheral Blood in Oncology. Blood-Derived Transcriptomic
Profiles as a Means to Monitor Levels of Toxicant Exposure and the Effects
of Toxicants on Inaccessible Target Tissues. Spermatozoal RNAs as Surrogate
Markers of Paternal Exposure. PROTEOMIC APPROACHES. Proteomic Analysis of
Surrogate Tissues: Mass Spectrometry-Based Profiling of the Circulatory
Proteome for Cancer Detection and Stratification. Lymphocyte Integrins:
Potential Surrogate Biomarkers for Evaluation of Endometrial Receptivity.
Nipple Aspirate Fluid to Diagnose Breast Cancer and Monitor Response to
Treatment. METABOLOMICS AND OTHER APPROACHES. Metabonomics: Metabolic
Profiling and Pattern Recognition Analysis of Body Fluids and Tissues for
Characterization of Drug Toxicity and Disease Diagnosis. Comprehensive
Metabolomic Profiling of Serum and Cerebrospinal Fluid: Understanding
Disease, Human Variability, and Toxicity. Lipidomic Analysis of Plasma and
Tissues: Lipid-Derived Mediators of Inflammation and Markers of Disease.
Molecular Detection and Characterization of Circulating Tumor Cells and
Micrometastases in Solid Tumors. Methylation Profiling of Tumor Cells and
Tumor DNA in Blood, Urine, and Body Fluids for Cancer Detection and
Monitoring. FUTURE CONSIDERATIONS FOR SURROGATE TISSUE PROFILING.
Regulatory and Technical Challenges in Incorporating Surrogate Tissue
Profiling Strategies into Clinical Development Programs. Considerations in
the Economic Assessment of the Value of Molecular Profiling. The Impact and
Challenges of Pan-Omic Approaches in Pharmaceutical Discovery and
Development. Current and Future Aspects of Surrogate Tissue Analysis.
References.